2024    2023    2022    2021    2020    2019    2018    2017    2016   

2018

Articles

31 - 

Designed Surface Topographies Control ICAM-1 Expression in Tonsil-Derived Human Stromal Cells

Aliaksei S Vasilevich, Frédéric Mourcin, Anouk Mentink, Frits Hulshof, Nick Beijer, Yiping Zhao, Marloes Levers, Bernke Papenburg, Shantanu Singh, Anne E Carpenter et al.

Frontiers in Bioengineering and Biotechnology, 2018, 6, pp.87.

DOI : https://doi.org/10.3389/fbioe.2018.00087

Pubmed : 30003080

 

32 - 

Definition of a minimal genes set for mature lymphoid blood diseases

Pierre Sujobert, Yannick Le Bris, Laurence de Leval, Audrey Gros, Jean Philippe Merlio, Cedric Pastoret, Sarah Huet, Clémentine Sarkozy, Frederic Davi, Mary Callanan et al.

Hématologie, 2018, 24 (1), pp.27-59.

DOI : https://doi.org/10.1684/hma.2018.1315

 

33 - 

Biomarqueurs prédictifs de réponse aux inhibiteurs de points de contrôle immuns

Karin Tarte, Jean Mosser, Julien Edeline, Alexandra Frelau, Marc Pracht, Samuel Le Sourd, Alexandra Lespagnol, Romain Corre, Cédric Ménard

Bulletin du Cancer, 2018, 105 Suppl 1, pp.S80-S91.

DOI : https://doi.org/10.1016/S0007-4551(18)30393-X

Pubmed : 30595202

 

34 - 

High sensitivity of the Hematoflow™ solution for chronic myelomonocytic leukemia screening

Romain Vazquez, Mikaël Roussel, Bouchra Badaoui, Nicolas Freynet, Sihem Tarfi, Eric Solary, Dorothée Selimoglu-Buet, Orianne Wagner-Ballon

Cytometry Part B: Clinical Cytometry, 2018, 94 (5), pp.658-661.

DOI : https://doi.org/10.1002/cyto.b.21600

Pubmed : 29108126

 

35 - 

Lymphoid-like extracellular matrix partially polarizes stroma cells toward a lymphoid phenotype

L. Verdiere, D. Roulois, V. Sibut, F. Mourcin, K. Tarte

International Journal of Experimental Pathology, 2018, 99 (6), pp.A39-A40.

DOI : https://doi.org/10.1111/iep.12294

 

36 - 

Microenvironment signaling driving lymphomagenesis

Léa Verdière, Frédéric Mourcin, Karin Tarte

Current Opinion in Hematology, 2018, 25 (4), pp.335 - 345.

DOI : https://doi.org/10.1097/MOH.0000000000000440

Pubmed : 29746265

 

37 - 

NK cell activation and recovery of NK cell subsets in lymphoma patients after obinutuzumab and lenalidomide treatment

Dang-Nghiem Vo, Catherine Alexia, Nerea Allende-Vega, Franck Morschhauser, Roch Houot, Cédric Menard, Karin Tarte, Guillaume Cartron, Martin Villalba

OncoImmunology, 2018, 7 (4), pp.e1409322.

DOI : https://doi.org/10.1080/2162402X.2017.1409322

Pubmed : 29632722

 

38 - 

Sensitive tumour detection and classification using plasma cell-free DNA methylomes

Shu Yi Shen, Rajat Singhania, Gordon Fehringer, Ankur Chakravarthy, Michael H. A. Roehrl, Dianne Chadwick, Philip C. Zuzarte, Ayelet Borgida, Ting Ting Wang, Tiantian Li et al.

Nature, 2018, 563 (7732), pp.579-583.

DOI : https://doi.org/10.1038/s41586-018-0703-0

Pubmed : 30429608

 

39 - 

Hide or defend, the two strategies of lymphoma immune evasion potential implications for immunotherapy

Marie de Charette, Roch Houot

Haematologica, 2018, 103 (8), pp.1256-1268.

DOI : https://doi.org/10.3324/haematol.2017.184192

Pubmed : 30006449

 

Posters

40 - 

B cell differentiation is defective in Multiple Sclerosis patients

Jérémy Morille, M. Chesneau, F. Lejeune, A. Garcia, L. Berthelot, A. Nicot, Sophie Brouard, David-Axel Laplaud, L. Michel

Labex IGO, Apr 2018, Nantes, France.